TotalMarketCap

Arcutis Biotherapeutics

ARQTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.416 B

$27.01 -20.68%

Close of 6 Nov 2026

As of 6 Nov 2026, Arcutis Biotherapeutics (ARQT) has a market capitalization of $3.42B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$376.1M

#2031 by revenue

Earnings

-$16.1M

Loss-making

Shares outstanding

126,455,033

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #66Disc MedicineIRON$3.49B
  2. #67Amylyx PharmaceuticalsAMLX$3.48B
  3. #68Arcutis BiotherapeuticsARQT$3.42B
  4. #69Parabilis MedicinesPBLS$3.41B
  5. #70Viking TherapeuticsVKTX$3.29B

What if Arcutis Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$223,295.77

Per share 8,267× higher

Bitcoin $1.53T

$12,082.15

Per share 447× higher

Apple $5.02T

$39,664.56

Per share 1,469× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Arcutis Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.